ImmunologybioRxivPreprint
Development of SARS-CoV-2 mRNA vaccines encoding spike N-terminal and receptor binding domains
G. Stewart-Jones, S. M. Elbashir, K. Wu…·A. Carfi
The paper develops and evaluates an mRNA vaccine, mRNA-1283, encoding SARS-CoV-2 spike N-terminal and receptor-binding domains, showing improved immunogenicity and protection against multiple variants in mice.